Fox Advisors upgraded Amphenol from Equal Weight to Overweight and set a new price target of $85.00
Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/24/2025 | $85.00 | Equal Weight → Overweight | Fox Advisors |
| 9/4/2024 | $80.00 → $71.00 | Buy → Neutral | BofA Securities |
| 7/23/2024 | $65.00 | Hold | Vertical Research |
| 5/20/2024 | $150.00 | Buy | Seaport Research Partners |
| 4/9/2024 | $125.00 | Hold | Jefferies |
| 1/5/2024 | $117.00 | Buy | Citigroup |
| 10/5/2023 | $93.00 | Outperform | Exane BNP Paribas |
| 5/19/2023 | $91.00 → $77.00 | Outperform → Neutral | Credit Suisse |
CERT - AMPHENOL CORP /DE/ (0000820313) (Filer)
8-A12B - AMPHENOL CORP /DE/ (0000820313) (Filer)
8-K - AMPHENOL CORP /DE/ (0000820313) (Filer)
Amphenol Corporation (NYSE:APH) (the "Company") announced today the pricing of its offering of €600 million aggregate principal amount of senior notes due 2032 (the "Euro Notes"). The Euro Notes will have an interest rate of 3.125% per annum. The closing of the offering of Euro Notes (the "Euro Notes Offering") is expected to occur on June 16, 2025, subject to the satisfaction of customary closing conditions. On June 9, 2025, the Company announced the pricing of its offering of $750 million aggregate principal amount of 4.375% senior notes due 2028 (the "USD Notes") by means of a separate prospectus supplement. The closing of the offering of the USD Notes (the "USD Notes Offering") is exp
Amphenol Corporation (NYSE:APH) (the "Company") announced today the pricing of its offering of $750 million aggregate principal amount of senior notes due 2028 (the "USD Notes"). The USD Notes will have an interest rate of 4.375% per annum. The closing of the offering of USD Notes (the "USD Notes Offering") is expected to occur on June 12, 2025, subject to the satisfaction of customary closing conditions. Substantially concurrently with or shortly after the USD Notes Offering, the Company expects to offer, by means of a separate prospectus supplement, euro-denominated notes (the "Euro Notes"). Neither the completion of the USD Notes Offering nor the offering of the Euro Notes (the "Euro N
Amphenol Corporation (NYSE:APH) announced today that its Board of Directors approved the second quarter 2025 dividend on its Common Stock in the amount of $0.165 per share at its meeting held on April 30, 2025. The Company will pay this second quarter 2025 dividend on July 9, 2025 to shareholders of record as of June 17, 2025. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 count
Fox Advisors upgraded Amphenol from Equal Weight to Overweight and set a new price target of $85.00
BofA Securities downgraded Amphenol from Buy to Neutral and set a new price target of $71.00 from $80.00 previously
Vertical Research initiated coverage of Amphenol with a rating of Hold and set a new price target of $65.00
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
4 - AMPHENOL CORP /DE/ (0000820313) (Issuer)
Amphenol Corporation (NYSE:APH) announced today that its Board of Directors approved the second quarter 2025 dividend on its Common Stock in the amount of $0.165 per share at its meeting held on April 30, 2025. The Company will pay this second quarter 2025 dividend on July 9, 2025 to shareholders of record as of June 17, 2025. About Amphenol Amphenol Corporation is one of the world's largest designers, manufacturers and marketers of electrical, electronic and fiber optic connectors and interconnect systems, antennas, sensors and sensor-based products and coaxial and high-speed specialty cable. Amphenol designs, manufactures and assembles its products at facilities in approximately 40 count
First Quarter 2025 Highlights: Record Sales of $4.8 billion, up 48% in U.S. dollars and 33% organically compared to the first quarter of 2024 GAAP Diluted EPS of $0.58, up 32% compared to prior year Record Adjusted Diluted EPS of $0.63, up 58% compared to prior year GAAP and Record Adjusted Operating Margin of 21.3% and 23.5%, respectively Operating and Free Cash Flow of $765 million and $580 million, respectively Completed two acquisitions: LifeSync and CommScope's OWN and DAS businesses Amphenol Corporation (NYSE:APH) today reported record first quarter 2025 results. "We are pleased to have closed the first quarter of 2025 with record sales and Adjusted Diluted EPS, both si
Amphenol Corporation (NYSE:APH) today announced it had completed the acquisition of CommScope's (NASDAQ:COMM) Outdoor Wireless Networks (OWN) and Distributed Antenna Systems (DAS) businesses. "The acquisition of the OWN and DAS businesses brings to Amphenol a strong portfolio of innovative and advanced technologies for communications networks," said Amphenol President and Chief Executive Officer, R. Adam Norwitt. "We are excited to welcome nearly 4,000 talented employees to the Amphenol family and look forward to further supporting our customers who are developing next-generation wireless networks around the world." Amphenol expects the OWN and DAS businesses to generate full-year 2025
TAMPA, Fla. and CORAL SPRINGS, Fla., Feb. 18, 2025 /PRNewswire/ -- HealthEdge Investment Partners, LLC ("HealthEdge"), a lower middle market private equity fund focused on healthcare, announced today that it has completed the sale of LifeSync ("LifeSync" or the "Company"), a developer, manufacturer, and marketer of disposable and reusable patient monitoring devices and connections sold to hospitals and other high acuity settings. LifeSync was acquired by Amphenol (NYSE:APH), one of the world's largest providers of connectors, interconnect systems, antennas, sensors and specialty cable. "When we first invested in LifeSync, our objective was to grow revenues and scale an entrepreneurial busin
SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)
SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)
SC 13G/A - AMPHENOL CORP /DE/ (0000820313) (Subject)